You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020101023
Dec 20202205
Jan 20212606
Feb 20211403
Mar 20213008
Apr 20211805
May 2021502
Jun 2021005
Jul 2021003
Aug 2021005
Sep 2021003
Oct 202134019
Nov 202116014
Dec 2021400
Jan 202214010
Feb 20221002
Mar 2022808
Apr 20223206
May 20221609
Jun 20221602
Jul 20221400
Aug 20222002
Sep 2022601
Oct 20221000
Nov 2022802
Dec 20221801
Jan 20231200
Feb 20231803
Mar 2023601
Apr 20231003
May 20231401
Jun 2023203
Jul 20231204
Aug 2023402
Sep 2023802
Oct 20231002
Nov 20231601
Dec 20232000
Jan 20241801
Feb 20242202
Mar 20241200
Apr 2024602
May 20243000
Jun 20244200
Jul 20241204
Aug 20242002
Sep 20241003
Total7460180